BSE filing, NSE: ACKNIT. Summary written from the filing by ALFA Finder's alert engine.
Acknit Industries Ltd: key numbers
- Share price
- ₹289.05
- Market cap
- ₹87.87 Cr
- Revenue (annual)
- ₹240.4 Cr
- Net profit (annual)
- ₹8.18 Cr
- P/E (TTM)
- 10.2×Sector 52.0×
- Promoter holding
- 56.13%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Acknit Industries Ltd
All →Acknit Industries Annual General Meeting
Acknit Industries held its 36th Annual General Meeting on September 16, 2026, via video conferencing to transact ordinary and special business items for shareholders.
Acknit Industries Management Change
Acknit Industries Limited announced the demise of Independent Director Mr. Shankar Lal Bajaj, who passed away on 21st August 2026. He ceased to be a director effectively.
Acknit Industries Annual General Meeting
Acknit Industries Limited has scheduled its 36th Annual General Meeting for September 16, 2026. The meeting will address dividend declaration and director appointments.
Acknit Industries Annual Report
Acknit Industries has filed its Annual Report for the financial year 2025-26. The report includes the notice for the 36th Annual General Meeting to be held.
Acknit Industries Q1 FY27 Results: Net Profit ₹2.2 Cr, Up 29.4% YoY
Acknit Industries Ltd reported revenue from operations of ₹62.1 Cr (+12.5% YoY) and net profit of ₹2.2 Cr (+29.4% YoY) for Q1 FY27.
- Key figure
- Net profit ₹2.2 Cr · +29.4% YoY
Acknit Industries Board Meeting Date
Acknit Industries has scheduled a board meeting for August 10, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.